Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry Study

Marie Skougaard; Tanja Schjødt Jørgensen; Signe Rifbjerg-Madsen; Laura C Coates; Alexander Egeberg; Kirstine Amris; Lene Dreyer; Pil Højgaard; Jørgen Guldberg-Møller; Joseph F Merola; Peder Frederiksen; Henrik Gudbergsen; Lars Erik Kristensen

doi:10.3899/jrheum.181412

Relationship Between Fatigue and Inflammation, Disease Duration, and Chronic Pain in Psoriatic Arthritis: An Observational DANBIO Registry Study

J Rheumatol. 2020 Apr;47(4):548-552. doi: 10.3899/jrheum.181412. Epub 2019 Jul 15.

Authors

Marie Skougaard^{1

2}, Tanja Schjødt Jørgensen^{1

2}, Signe Rifbjerg-Madsen^{1

2}, Laura C Coates^{1

2}, Alexander Egeberg^{1

2}, Kirstine Amris^{1

2}, Lene Dreyer^{1

2}, Pil Højgaard^{1

2}, Jørgen Guldberg-Møller^{1

2}, Joseph F Merola^{1

2}, Peder Frederiksen^{1

2}, Henrik Gudbergsen^{1

2}, Lars Erik Kristensen^{3

4}

Affiliations

¹ From The Parker Institute, and the Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Dermatology and Allergy, Copenhagen University Hospital Gentofte and Herlev, Gentofte; departments of Clinical Medicine and Rheumatology, Aalborg University and Aalborg University Hospital, Aalborg; The DANBIO Registry, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup; the Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Gentofte and Herlev, Gentofte, Denmark; Department of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² M. Skougaard, MD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; T.S. Jørgensen, MSc, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; S. Rifbjerg-Madsen, MD, PhD, The Parker Institute, and the Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg; L.C. Coates, MBChB, MRCP, PhD, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; A. Egeberg, MD, PhD, Department of Dermatology and Allergy, Copenhagen University Hospital Gentofte and Herlev; K. Amris, MD, DMsc, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; L. Dreyer, MD, Professor, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, and the departments of Clinical Medicine and Rheumatology, Aalborg University and Aalborg University Hospital, and the DANBIO Registry, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet; P. Højgaard, MD, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, and Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Gentofte and Herlev; J. Guldberg-Møller, MD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; J.F. Merola, MD, MMSc, Department of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School; P. Frederiksen, MSc, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; H. Gudbergsen, MD, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; L.E. Kristensen, MD, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg.
³ From The Parker Institute, and the Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Department of Dermatology and Allergy, Copenhagen University Hospital Gentofte and Herlev, Gentofte; departments of Clinical Medicine and Rheumatology, Aalborg University and Aalborg University Hospital, Aalborg; The DANBIO Registry, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup; the Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Gentofte and Herlev, Gentofte, Denmark; Department of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. lars.erik.kristensen@regionh.dk.
⁴ M. Skougaard, MD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; T.S. Jørgensen, MSc, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; S. Rifbjerg-Madsen, MD, PhD, The Parker Institute, and the Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg; L.C. Coates, MBChB, MRCP, PhD, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford; A. Egeberg, MD, PhD, Department of Dermatology and Allergy, Copenhagen University Hospital Gentofte and Herlev; K. Amris, MD, DMsc, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; L. Dreyer, MD, Professor, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, and the departments of Clinical Medicine and Rheumatology, Aalborg University and Aalborg University Hospital, and the DANBIO Registry, Center for Rheumatology and Spine Diseases, Centre for Head and Orthopaedics, Rigshospitalet; P. Højgaard, MD, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg, and Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Gentofte and Herlev; J. Guldberg-Møller, MD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; J.F. Merola, MD, MMSc, Department of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School; P. Frederiksen, MSc, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; H. Gudbergsen, MD, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg; L.E. Kristensen, MD, PhD, The Parker Institute, Copenhagen University Hospital, Bispebjerg and Frederiksberg. lars.erik.kristensen@regionh.dk.

PMID: 31308213
DOI: 10.3899/jrheum.181412

Abstract

Objective: Fatigue is one of the most significant symptoms, and an outcome of great importance, in patients with psoriatic arthritis (PsA), but associations between underlying components of fatigue experienced by patients in relation to the disease have been sparsely investigated. The objectives were to describe the degree of fatigue in patients with PsA, and to examine important components associated with fatigue.

Methods: We performed a cross-sectional survey including patients registered in the Danish nationwide registry DANBIO from December 2013 to June 2014. Principal component analysis (PCA) was used to identify factors associated with fatigue.

Results: A total of 1062 patients with PsA were included in the study. A PCA reduced co-variables into 3 components explaining 63% of fatigue in patients. The first component, contributing to 31% of fatigue, was composed of inflammatory factors including swollen and tender joints, physician's global assessment, elevated C-reactive protein (CRP), and high Pain Detect Questionnaire (PDQ) score. The second component, contributing to 17% of fatigue, consisted of increasing age and long disease duration. The third component, contributing to 15% of fatigue, consisted of high PDQ score, tender joint count, increasing age, and concomitant low CRP, suggestive of a chronic pain component consisting of central pain sensitization or structural joint damage.

Conclusion: Fatigue in patients with PsA may be driven by clinical inflammatory factors, disease duration, and chronic pain in the absence of inflammation.

Keywords: FATIGUE; PRINCIPAL COMPONENT ANALYSIS; PSORIATIC ARTHRITIS.

Publication types

Observational Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Arthritis, Psoriatic* / complications
Chronic Pain* / epidemiology
Chronic Pain* / etiology
Cross-Sectional Studies
Fatigue / epidemiology
Fatigue / etiology
Humans
Inflammation
Registries